United States · FDA National Drug Code directory

Oxybutynin Chloride Extended Release

A source-listed medicine record.

Factual source checks only. This page is not a clinically reviewed monograph. Historical or discontinued records may be included; listing does not confirm approval, current availability or pharmacy stock.

Medicine identity

Source reference: 43353-285_9eda2c93-de21-45ec-a9dc-1329d6d44be7
Product NDC: 43353-285
Form: TABLET, EXTENDED RELEASE
Composition / generic term: Oxybutynin Chloride
Labeler: Aphena Pharma Solutions - Tennessee, LLC
Marketing category: ANDA
Marketing start / end (source format): 20090301
Source listing expiry: 20261231

Source-listed ingredients

OXYBUTYNIN CHLORIDE — 5 mg/1

These values do not establish equivalence or a dose recommendation.

Packages

30 TABLET, EXTENDED RELEASE in 1 BOTTLE (43353-285-30) · 43353-285-30
60 TABLET, EXTENDED RELEASE in 1 BOTTLE (43353-285-53) · 43353-285-53
90 TABLET, EXTENDED RELEASE in 1 BOTTLE (43353-285-60) · 43353-285-60

Source and coverage

Open FDA National Drug Code directory →

Snapshot retrieved: 2026-09-17. This is the acquisition date, not a medical review date.

Clinical information, images and comparisons appear only when separately reviewed for this record. Coverage may be incomplete. Ask a pharmacist or clinician about your treatment.

Browse United States records →